换一批
第一作者：
Shu,Feng
第一单位：
Department of Pathology and Immunology, Baylor College of Medicine and Michael E. DeBakey Department of Veterans Affairs Medical Center Baylor College of Medicine, Houston, 77030, TX, USA.
作者：
医学主题词
动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);苯甲酰胺类(Benzamides);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);剂量效应关系, 药物(Dose-Response Relationship, Drug);细胞外信号调节MAP激酶类(Extracellular Signal-Regulated MAP Kinases);人类(Humans);男(雄)性(Male);小鼠, SCID(Mice, SCID);磷酰化(Phosphorylation);哌嗪类(Piperazines);前列腺肿瘤(Prostatic Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);吡唑类(Pyrazoles);嘧啶类(Pyrimidines);吡咯类(Pyrroles);受体, 成纤维细胞生长因子, 1型(Receptor, Fibroblast Growth Factor, Type 1);STAT3转录因子(STAT3 Transcription Factor);信号传导(Signal Transduction);肿瘤负荷(Tumor Burden);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.18632/oncotarget.14049
PMID
28008155
发布时间
2022-02-23
- 浏览9
Oncotarget
6179-6192页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
